Raymond Anderson
Director/Board Member bei MONOPAR THERAPEUTICS INC.
Vermögen: 18 294 $ am 31.03.2024
Profil
Raymond W.
Anderson currently works at Monopar Therapeutics, Inc., as Independent Director from 2017.
Mr. Anderson also formerly worked at Dow Pharmaceutical Sciences, Inc., as Chief Financial Officer & Managing Director from 2003 to 2010, Raptor Pharmaceuticals Corp., as Director, Horizon Pharmaceutical LLC, as Independent Director from 2012 to 2016, Chiron Corp., as Principal, Glycomed, Inc., as Principal, Syntex Corp., as Principal, Fusion Medical Technologies, Inc., as Principal, BioMarin Pharmaceutical, Inc., as Chief Operating & Financial Officer from 1998 to 2001, ProRhythm, Inc., as Chief Financial Officer, and Memorex Corp., as Finance Manager.
Mr. Anderson received his Masters Business Admin degree from Harvard University, graduate degree from George Washington University, and undergraduate degree from US Military Academy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MONOPAR THERAPEUTICS INC
0,18% | 08.03.2024 | 26 863 ( 0,18% ) | 18 294 $ | 31.03.2024 |
Aktive Positionen von Raymond Anderson
| Unternehmen | Position | Beginn |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Director/Board Member | 01.04.2017 |
Ehemalige bekannte Positionen von Raymond Anderson
| Unternehmen | Position | Ende |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Director/Board Member | 25.10.2016 |
Dow Pharmaceutical Sciences, Inc.
 Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Director of Finance/CFO | 01.06.2010 |
| BIOMARIN PHARMACEUTICAL INC. | Director of Finance/CFO | 01.01.2001 |
Memorex Corp.
 Memorex Corp. Information Technology ServicesTechnology Services Memorex Corp. provides information technology solutions. The private company is based in Norfolk, VA. | Corporate Officer/Principal | - |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Director/Board Member | - |
Ausbildung von Raymond Anderson
| Harvard University | Masters Business Admin |
| George Washington University | Graduate Degree |
| US Military Academy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Glycomed, Inc.
 Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Glycomed, Inc. discovers and developes pharmaceuticals based on complex carbohydrates. The company's drug discovery strategy utilizes medicinal chemistry to identify biologically active small molecules for therapeutic use. The company was founded by Brian G. Atwood in 1987 and is headquartered in San Diego, CA. | Health Technology |
| Syntex Corp. | Health Technology |
Fusion Medical Technologies, Inc.
 Fusion Medical Technologies, Inc. Medical SpecialtiesHealth Technology Fusion Medical Technologies, Inc. is used to develop, manufactures and market surgical hemostatic products like sutures and topical agents such as sponges which are used to stop bleeding in a variety of surgeries. The Company's product floSeal (R) matrix hemostatic sealant was used to control surgical bleeding. It products were used in a variety of surgical procedures like cardiac, vascular, spinal, ear, nose, throat, head, neck and cranial surgeries. The company marketed its products through direct sales force. It was headquartered in Fremont, CA. | Health Technology |
ProRhythm, Inc.
 ProRhythm, Inc. Medical SpecialtiesHealth Technology ProRhythm, Inc. provides medical services. It developed HIFU (High Intensity Focused Ultrasound) for the treatment of atrial fibrillation (AF) a debilitating arrhythmia. The company was founded by David E. Acker in 1997 and is headquartered in Ronkonkoma, NY. | Health Technology |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Medical DistributorsDistribution Services Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA. | Distribution Services |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Memorex Corp.
Memorex Corp. Information Technology ServicesTechnology Services Memorex Corp. provides information technology solutions. The private company is based in Norfolk, VA. | Technology Services |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
| Monopar Therapeutics, Inc. |
